These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 15503821

  • 1. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?
    Kayhan B, Kayhan B, Akdoğan M.
    Int J Biol Markers; 2004; 19(3):196-202. PubMed ID: 15503821
    [Abstract] [Full Text] [Related]

  • 2. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G, Spada OA, Rabitti PG, Feola B, Misso S, Minerva A, Uomo G.
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [Abstract] [Full Text] [Related]

  • 3. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
    Maire F, Micard S, Hammel P, Voitot H, Lévy P, Cugnenc PH, Ruszniewski P, Puig PL.
    Br J Cancer; 2002 Aug 27; 87(5):551-4. PubMed ID: 12189555
    [Abstract] [Full Text] [Related]

  • 4. Serum CA 242: the search for a valid marker of pancreatic cancer.
    Ventrucci M, Ubalducci GM, Cipolla A, Panella MA, Ligabue A.
    Clin Chem Lab Med; 1998 Mar 27; 36(3):179-84. PubMed ID: 9589807
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of soluble interleukin-2 receptor-alpha in adenocarcinoma of the pancreas.
    Gansauge F, Steinbach G, Gansauge S, König HH, Müller J, Grünert A, Beger HG.
    Cancer Lett; 1998 Dec 25; 134(2):193-9. PubMed ID: 10025881
    [Abstract] [Full Text] [Related]

  • 6. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R, Billi P, Beltrandi E, Mancini R, Casadei-Maldini M, Casadei R, Greco VM, Campione O, Miglioli M.
    Ital J Gastroenterol; 1994 Apr 25; 26(3):137-40. PubMed ID: 8061340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    Yan T, Ke Y, Chen Y, Xu C, Yu C, Li Y.
    PLoS One; 2017 Apr 25; 12(4):e0174735. PubMed ID: 28369140
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
    Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S.
    Int J Pancreatol; 1994 Jun 25; 15(3):171-7. PubMed ID: 7930777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
    Clavé P, Boadas J, González-Carro P, Mora J, Pérez C, Martínez A, Roca M, Lluís F, Farré A.
    Gastroenterol Hepatol; 1999 Jun 25; 22(7):335-41. PubMed ID: 10535205
    [Abstract] [Full Text] [Related]

  • 13. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
    Markocka-Maczka K.
    Wiad Lek; 2003 Jun 25; 56(11-12):537-40. PubMed ID: 15058160
    [Abstract] [Full Text] [Related]

  • 14. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
    Birk D, Gansauge F, Gansauge S, Formentini A, Lucht A, Beger HG.
    Int J Pancreatol; 1999 Apr 25; 25(2):89-96. PubMed ID: 10360220
    [Abstract] [Full Text] [Related]

  • 15. Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis.
    Tanţău A, Leucuţa DC, Tanţău M, Boţan E, Zaharie R, Mândruţiu A, Tomuleasa IC.
    Dig Dis Sci; 2021 Oct 25; 66(10):3427-3438. PubMed ID: 33184795
    [Abstract] [Full Text] [Related]

  • 16. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
    Ventrucci M, Cipolla A, Racchini C, Casadei R, Simoni P, Gullo L.
    Dig Dis Sci; 2004 Aug 25; 49(7-8):1149-55. PubMed ID: 15387337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
    Nouts A, Lévy P, Voitot H, Bernades P.
    Gastroenterol Clin Biol; 1998 Feb 25; 22(2):152-9. PubMed ID: 9762189
    [Abstract] [Full Text] [Related]

  • 19. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J, Sokoll LJ, Pasay JJ, Rubin AL, Li H, Bach DM, Chan DW, Zhang Z.
    Cancer Epidemiol Biomarkers Prev; 2019 Jan 25; 28(1):174-182. PubMed ID: 30333219
    [Abstract] [Full Text] [Related]

  • 20. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC, Liang PC, Jan S, Yang CY, Tien YW, Wei SC, Wong JM, Chang YT.
    Pancreatology; 2014 Jan 25; 14(5):366-72. PubMed ID: 25278306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.